Kannalife

Biotechnology, Health Care, Pharmaceutical
Founded in 8/10/10
Doylestown, Pennsylvania, United States
For Profit

About Kannalife

Kannalife, a subsidiary of Neuropathix, Inc (OTCQB: NPTX), is a biopharmaceutical company focused on discovering, developing, and commercializing a product platform of novel molecules from our proprietary next-generation cannabinoid therapeutics as potent, non-opioid alternatives to treat patients with a variety of unmet medical needs.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: 19 active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 4470000 USD
  • Last Funding: 2970000 USD (Grant)
  • Funding Status:

Technology Stack

Kannalife actively uses 19 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Pharmaceutical

Headquarters: Doylestown, Pennsylvania, United States

Leadership